1. Home
  2. PBYI vs PHD Comparison

PBYI vs PHD Comparison

Compare PBYI & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • PHD
  • Stock Information
  • Founded
  • PBYI 2010
  • PHD 2004
  • Country
  • PBYI United States
  • PHD United States
  • Employees
  • PBYI N/A
  • PHD N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • PHD Investment Managers
  • Sector
  • PBYI Health Care
  • PHD Finance
  • Exchange
  • PBYI Nasdaq
  • PHD Nasdaq
  • Market Cap
  • PBYI 164.3M
  • PHD 120.3M
  • IPO Year
  • PBYI N/A
  • PHD N/A
  • Fundamental
  • Price
  • PBYI $3.54
  • PHD $9.89
  • Analyst Decision
  • PBYI Strong Buy
  • PHD
  • Analyst Count
  • PBYI 1
  • PHD 0
  • Target Price
  • PBYI $7.00
  • PHD N/A
  • AVG Volume (30 Days)
  • PBYI 306.9K
  • PHD 67.7K
  • Earning Date
  • PBYI 07-31-2025
  • PHD 01-01-0001
  • Dividend Yield
  • PBYI N/A
  • PHD 11.43%
  • EPS Growth
  • PBYI 143.51
  • PHD N/A
  • EPS
  • PBYI 0.77
  • PHD 1.27
  • Revenue
  • PBYI $232,709,000.00
  • PHD N/A
  • Revenue This Year
  • PBYI N/A
  • PHD N/A
  • Revenue Next Year
  • PBYI N/A
  • PHD N/A
  • P/E Ratio
  • PBYI $4.64
  • PHD $7.60
  • Revenue Growth
  • PBYI 2.68
  • PHD N/A
  • 52 Week Low
  • PBYI $2.23
  • PHD $8.30
  • 52 Week High
  • PBYI $4.13
  • PHD $9.81
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 58.61
  • PHD 69.64
  • Support Level
  • PBYI $3.26
  • PHD $9.79
  • Resistance Level
  • PBYI $3.65
  • PHD $9.83
  • Average True Range (ATR)
  • PBYI 0.14
  • PHD 0.05
  • MACD
  • PBYI 0.01
  • PHD 0.00
  • Stochastic Oscillator
  • PBYI 84.78
  • PHD 100.00

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About PHD Pioneer Floating Rate Fund Inc.

Pioneer Floating Rate Trust is a diversified, closed-end fund. It invests in the fixed income markets of the United States. The fund basically invests in senior secured floating-rate loans. It benchmarks the performance of its portfolio against the other High Yield Loans Index banks.

Share on Social Networks: